1. A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis. Issue 1 (2nd January 2017) Authors: Kobayashi, Shigeto; Yoshinari, Toru Journal: Modern rheumatology Issue: Volume 27:Issue 1(2017) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis. Issue 7 (8th April 2011) Authors: Takeuchi, Tsutomu; Miyasaka, Nobuyuki; Tatsuki, Yoshihiko; Yano, Toshiro; Yoshinari, Toru; Abe, Tohru; Koike, Takao Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 7(2011) Page Start: 1208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial. Issue 4 (3rd July 2016) Authors: Tanaka, Yoshiya; Harigai, Masayoshi; Takeuchi, Tsutomu; Yamanaka, Hisashi; Ishiguro, Naoki; Yamamoto, Kazuhiko; Miyasaka, Nobuyuki; Koike, Takao; Baker, Daniel; Ishii, Yutaka; Yoshinari, Toru Journal: Modern rheumatology Issue: Volume 26:Issue 4(2016) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120. Issue 5 (3rd September 2018) Authors: Takeuchi, Tsutomu; Harigai, Masayoshi; Tanaka, Yoshiya; Yamanaka, Hisashi; Ishiguro, Naoki; Yamamoto, Kazuhiko; Miyasaka, Nobuyuki; Koike, Takao; Ukyo, Yoshifumi; Ishii, Yutaka; Yoshinari, Toru; Baker, Daniel Journal: Modern rheumatology Issue: Volume 28:Issue 5(2018) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study. Issue 2 (25th August 2014) Authors: Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Kuki, Hideki Journal: Journal of diabetes investigation Issue: Volume 6:Issue 2(2015:Apr.) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study. Issue 2 (25th August 2014) Authors: Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Kuki, Hideki Journal: Journal of diabetes investigation Issue: Volume 6:Issue 2(2015:Apr.) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study. (August 2014) Authors: Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yutaka; Kuki, Hideki Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 11(2014) Page Start: 1501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study. (August 2014) Authors: Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yutaka; Kuki, Hideki Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 11(2014) Page Start: 1501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study. Issue 6 (25th November 2011) Authors: Tanaka, Yoshiya; Harigai, Masayoshi; Takeuchi, Tsutomu; Yamanaka, Hisashi; Ishiguro, Naoki; Yamamoto, Kazuhiko; Miyasaka, Nobuyuki; Koike, Takao; Kanazawa, Minoru; Oba, Takuya; Yoshinari, Toru; Baker, Daniel Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 6(2012) Page Start: 817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks. Issue 9 (14th September 2012) Authors: Takeuchi, Tsutomu; Harigai, Masayoshi; Tanaka, Yoshiya; Yamanaka, Hisashi; Ishiguro, Naoki; Yamamoto, Kazuhiko; Miyasaka, Nobuyuki; Koike, Takao; Kanazawa, Minoru; Oba, Takuya; Yoshinari, Toru; Baker, Daniel Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 9(2013) Page Start: 1488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗